Improving quality of life by supporting the accessibility of new treatments in research trials.

Meet the DR.Lima

Dr. Lima is the principal investigator at LEADER Research. He finished medical school at the Federal University of Ceará (Fortaleza, CE, Brazil) in 1989. Dr. Lima completed his Ph.D. with a major in Immunology at Harvard School of Public Health (Boston, MA, USA) in 1995. Research Fellow at Clinical Unit for Research Trials in Skin (CURTIS) – Massachusetts General Hospital – Harvard University (Boston, MA, USA) in 2008. He was appointed Associate Professor at Division of Dermatology, Department of Medicine, Michael G. DeGroote School of Medicine McMaster University (Hamilton, ON, Canada) in 2010. He was appointed Head of the Division of Dermatology, Department of Medicine, Michael G. DeGroote School of Medicine McMaster University in 2015. He created and is the Director and Principal Investigator of Lima’s Excellence in Allergy and Dermatology (LEADER) Research in 2018. He assumed the position of Associate Clinical Professor of Dermatology, Department of Medicine, Michael G. DeGroote School of Medicine McMaster University in 2010 (Hamilton, ON, Canada) in 2020. He started his private clinic activities at Dr. Lima’s Clinic in 2021. Dr. Lima’s main research interests are Immunodermatology with particular attention to Atopic Dermatitis, Hidradenitis Suppurativa, Psoriasis and Urticaria.. Dr. Lima published 78 articles in specialized journals and has 890 citations in ISI Web of Science and h index of 17. Dr. Lima has been PI or Sub PI in more than 40 Clinical Trials.

Sponsors

Recruiting Trials

clinical trial

Chronic Spontaneous Urticaria
RECRUITING

Phase 3 | Injection | 24 week treatment period | 8 week safety follow up

For children and adults (≥6 to 80) with chronic spontaneous urticaria (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Hidradenitis Suppurativa
RECRUITING

Phase 2 | Injection | 16 week treatment period | 8 week safety follow up

For adults (≥18) with moderate to severe hidradenitis suppurativa (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Hidradenitis Suppurativa
RECRUITING

Phase 2 | Injection | 24 week treatment period | 4 week safety follow up

For adults (≥18) with moderate to severe hidradenitis suppurativa (subcutaneous study drug)

CONTACT US TO LEARN MORE

Coming Soon Trials

clinical trial

Atopic Dermatitis
COMING SOON

Phase 2B | Injection | 16 week treatment period | 17 week safety follow up

For adults (≥18) with moderate to severe atopic dermatitis (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Atopic Dermatitis
COMING SOON

Phase 2B | Injection | 36 week treatment period | 20 week safety follow up

For adolescents (≥12 to <18) with moderate to severe atopic dermatitis (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Atopic Dermatitis
COMING SOON

Phase 3 | Injection | 24 week treatment period | 8 week safety follow up

For adults (≥18) with moderate to severe atopic dermatitis (subcutaneous study drug).

CONTACT US TO LEARN MORE

Not Recruiting Trials

clinical trial

Atopic Dermatitis
NOT RECRUITING

Phase 3 | Oral tablet | 260 week treatment period | 4 week safety follow up

For adolescents and adults (≥12 to 75) for moderate to severe atopic dermatitis (oral study drug)

CONTACT US TO LEARN MORE

clinical trial

Atopic Dermatitis
NOT RECRUITING

Observational study | Oral tablet | 24 month observation period

For patients starting JAK inhibitor treatment of moderate to severe atopic dermatitis (oral study drug)

CONTACT US TO LEARN MORE

clinical trial

Atopic Dermatitis
NOT RECRUITING

Phase 2 | Topical gel | 6 week treatment period | 2 week safety follow up

For adults (18 – 70) with mild to moderate atopic dermatitis (topical study drug)

CONTACT US TO LEARN MORE

clinical trial

Atopic Dermatitis
NOT RECRUITING

Phase 3 | Topical cream | 52 week treatment period | 4 week safety follow up

For children (≥ 2 and < 12 years) with atopic dermatitis (topical study drug)

CONTACT US TO LEARN MORE

clinical trial

Atopic Dermatitis
NOT RECRUITING

Observational study | Injection | 60 month observation period

For patients starting biologic treatment of moderate to severe atopic dermatitis (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Chronic Inducible Cold Urticaria
NOT RECRUITING

Phase 3 | Injection | 24 week treatment period | 8 week safety follow up

For adults and adolescents (≥12 – 80) with chronic inducible cold urticaria (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Chronic Spontaneous Urticaria
NOT RECRUITING

Phase 2B | Injection | 16 week treatment period | 16 week safety follow up

For adults (≥18 to 80) with chronic spontaneousurticaria (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Plaque Psoriasis
NOT RECRUITING

Observational study | Injection | 60 month observation period

For patients starting biologic treatment of moderate to severe chronic plaque psoriasis (subcutaneous study drug)

CONTACT US TO LEARN MORE

clinical trial

Plaque Psoriasis
NOT RECRUITING

Observational study | Injection | 37 month observation period

For patients starting biologic treatment of moderate to severe plaque psoriasis (subcutaneous study drug)

CONTACT US TO LEARN MORE

LEADER Research

Are you a sponsor looking for a research partner?

LEADER Research expertise includes:

Principal Investigator with 15+ years research experience, 30+ clinical trials participation in addition to extensive experience in Phase 2a, Phase 2b, and Phase 3 research
Access to a network of allergists / immunologists, dermatologists, and family physicians
Able to work with central IRB/REB
ICH/GCP and Good Documentation practices
Standard Operation Procedures
Numerous patients with a variety of illnesses from children to adults

CRO’S

Meet Our Staff

Kendra Antoniou RPN

Kendra is a study nurse at LEADER Research. She has a diverse nursing background working with individuals of all ages and backgrounds and has more than 4 years of experience working in different nursing fields.

Yuuki Hachitori HBSc

Yuuki is a clinic research coordinator at LEADER Research. He has a background in pharmacy and psychology.

Vivian Botelho Coginotti

Vivian is a clinical research coordinator. She is an international medical graduate rheumatologist with 10+ years of clinical research experience (50+ clinical trials) and a certified clinical research professional by SOCRA

Caroline Haiashi MD, MBA

Caroline is a clinical research coordinator. She has a background in medicine, healthcare project management and clinical research.